Searching over 5,500,000 cases.

Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

Rabbani v. Enzo Biochem


February 1, 2010


The opinion of the court was delivered by: Denise Cote, District Judge


Plaintiff sought a preliminary injunction to enjoin Enzo Biochem, Inc. ("Enzo") from conducting its annual shareholder meeting ("Shareholder Meeting") on January 29, 2010. The motion seeking a preliminary injunction was denied in an Order dated January 27, 2010, with an opinion to follow. This is the opinion.*fn1

The plaintiff Shahram K. Rabbani ("Rabbani") is a co-founder of Enzo and a member of its board. Rabbani brings claims against Enzo and six individual defendants who are Enzo directors for violations of federal securities laws and New York statutory and common law.*fn2 Rabbani filed a motion for a preliminary injunction on January 11. He seeks, inter alia, a delay of the Shareholder Meeting until no earlier than March 15, 2010.

Pursuant to this Court's individual practices, and with the consent of the parties, the direct testimony of the witnesses for the preliminary injunction hearing was submitted by affidavit. Rabbani submitted declarations from himself; Andre de Bruin, at one time nominated by Rabbani as a candidate for director of Enzo; and Norma J. McDaniel, Avie Roy, William R. Stansbury, Jan W. Vandersande, Marvin Miller, and Richard Miller, all shareholders of record of Enzo.*fn3 The defendants submitted declarations from defendants Barry Weiner ("Weiner"), Stephen B.H. Kent, Irwin C. Gerson, Bernard L. Kasten, and Melvin F. Lazar; Andrew R. Crescenzo ("Crescenzo"), the Senior Vice President of Finance for Enzo; and David C. Goldberg ("Goldberg"), the Vice President of Corporate Development at Enzo. Following the service of the preliminary injunction papers, the parties consented to the submission of this motion on that paper record. Based on those submissions, the following constitutes the Court's findings of fact and conclusions of law.


Enzo is a publicly held corporation organized under the laws of the State of New York. It is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics, and therapeutics. Rabbani co-founded Enzo in 1976 with his brother, Dr. Elazar Rabbani (Dr. Rabbani), and their brother-in-law, Weiner. Rabbani previously served as the company's chief operating officer and chief financial officer. More recently, he served until March 5, 2009 as the president of the company's largest subsidiary; and until November 25, 2009 as Secretary and Treasurer of Enzo. Rabbani owns approximately 3.8% of the outstanding shares of Enzo. Dr. Rabbani is the Chief Executive Officer, Chairman of the Board, and Secretary of Enzo. Weiner is President, Chief Financial Officer, Principal Accounting Officer, Treasurer, and a director of the company.

There are seven members of Enzo's board of directors, split into three classes. Each class serves a term of three years. There were three vacancies on the board to be filled in January 2010.

Enzo's Bylaws

Several of the issues raised in this litigation rest on the application of Enzo's Amended and Restated By-Laws ("the Bylaws"). The pertinent provisions of the Bylaws include its description of the method by which a shareholder may nominate candidates to serve as directors of the Company. The Bylaws require that each notice of intent to nominate directors contain specified information as well as such other information regarding each nominee proposed by such shareholder as would be required to be included in a proxy statement filed pursuant to the proxy rules of the Securities and Exchange Commission, had the nominee been nominated, or intended to be nominated, by the Board. (Emphasis supplied.) The Bylaws allow the chairman of the meeting to "refuse to acknowledge the nomination of any person not made in compliance with the foregoing procedure."

According to the Bylaws, a shareholder may nominate directors on written notice given either sixty or seven days in advance of a shareholder meeting, depending on whether the shareholder meeting is the annual meeting or a special meeting for the election of directors. The Bylaws provide: only if written notice of such shareholder's intent to make such nomination has been given... to the Secretary of the Corporation not later than (i) with respect to an election to be held at an annual meeting of shareholders, 60 days in advance of such meeting, and (ii) with respect to an election to be held at a special meeting of shareholders for the election of directors, the close of business on the seventh day following the date on which notice of such meeting is first given to shareholders. (Emphasis supplied.) Under the Bylaws, the annual meeting must take place in the month of January. Specifically, the Bylaws require that the annual shareholder meeting "be held during the sixth month following the close of the Corporation's fiscal year." Since Enzo's fiscal year ends in July, the meeting must be held during the month of January.

The Bylaws also require that shareholders be given written notice of all shareholder meetings:

Notice of the place, date and time of the holding of each annual and special meeting of the shareholders and, in the case of a special meeting, the purpose or purposes, thereof, shall be given personally or by mail in a postage prepaid envelope to each shareholder entitled to vote at such meeting, not less than ten nor more than fifty days before the date of such meeting....

Rabbani Notifies Enzo of Intent to Nominate Directors Enzo's annual Form 10-K, filed with the U.S. Securities and Exchange Commission ("SEC") on October 14, 2009, disclosed that the annual shareholder meeting would be held "on or about January 26, 2010." On October 21, Goldberg informed the board of directors that the annual shareholder meeting would take place on January 19, 2010. As already noted, the Bylaws require the annual meeting to be held no later than January, and that had been the company's practice for approximately the last twenty years.

In an effort to comply with the Bylaws' requirement of sixty days notice of nominations in advance of an annual shareholder meeting, on November 20, Rabbani advised Enzo in writing that he was nominating three persons for election to the board of directors ("the Nomination Letter"): Joseph V. Gulfo, Steven Katz, and Andre de Bruin.

On November 23, Enzo distributed an agenda for a November 25 board meeting that listed a February 9 date for the annual meeting. It read, "Notice of Annual Meeting Information: Record Date-December 14, 2009; Meeting date-February 9, 2010." Consistent with the agenda, on that same date, Crescenzo notified Broadridge Investor Communications Solutions ("Broadridge"), the proxy server hired by Enzo; American Stock Transfer & Trust Company, Enzo's transfer agent ("American Stock Transfer"); and an entity called CEDE & Co., described as the company in whose name most "street named" shares are held (collectively, "the Proxy Entities"), that the annual shareholder meeting date was being changed to February 9.

Almost immediately, however, Enzo reversed course and decided to proceed with its annual meeting in January, as required by its Bylaws. On November 24, Enzo's outside counsel sent an email to Crescenzo that said "Changing annual mtg date to january 29." Crescenzo promptly informed some of the Proxy Entities that the meeting date would be January 29.*fn4 Neither Enzo nor its counsel advised Rabbani at that time of the January 29 meeting date.

November 25 Board Meeting

At the November 25 meeting of Enzo's board of directors, the board removed Rabbani as Secretary and Treasurer. It also established a Stockholder Meeting Committee ("Committee") composed of Dr. Rabbani and Weiner. It explained the reasons for creating the special committee in a resolution, which reads in pertinent part:

WHEREAS, to properly and more efficiently manage... and work with the Company's management and outside professional advisors with respect to planning, strategizing, soliciting votes and convening the Company's 2009 Annual Meeting or, to the extent such meeting is not held on or before January 31, 2010, any subsequent special meeting of the Company's stockholders at which Company directors are to be elected and the matters to be acted upon and presented thereat including, without limitation, communicating with the Company's stockholders and addressing any potential opposition election campaign to be instituted by Shahram K.

Rabbani or any other stockholder of the Company, the Company's directors have determined that it is in the best interest of the Company for a committee of the Board to be constituted and established for the aforementioned purposes. (Emphasis supplied.) The Resolution also states that the Committee "shall report from time to time to the entire Board."

At the November 25 meeting, Rabbani asked Enzo's outside counsel what had happened to the shareholder meeting date of February 9th listed on the agenda, and the outside counsel told him that the "February 9 date was out" and that there was no new shareholder meeting date. No one at the meeting advised Rabbani that the annual meeting would be held in January, although as the Resolution quoted above reflects, the Board was on notice that if the annual meeting was not held before the end of January, any subsequent meeting would be a "special meeting."

Also on November 25, Dr. Rabbani wrote Rabbani to reject the Nomination Letter. Dr. Rabbani's letter asserted that the Nomination Letter "fails to comply with the requirements of Section 15 of Article II of the Company's Amended and Restated By-Laws currently in effect. It is the Committee's and the Board's position, therefore, that your letter is invalid and of no effect." The letter went on to say that, notwithstanding that conclusion, "the Company intends, voluntarily, to provide you a list of the record and beneficial owners of the Company's common stock." It also confirmed that the Board had removed Rabbani as an officer of the Company and reminded him of his fiduciary duties to the company and its stockholders.

Rabbani and Enzo Speak with Two Shareholders

From November 25 until December 30, Rabbani and Enzo and their counsel exchanged a series of letters debating the effectiveness of the Nomination Letter. Rabbani did not resubmit the Nomination Letter to include the information that Enzo alleged was missing or incomplete.

On November 30, the Committee set December 29 as the record date for determining shareholders of Enzo for purposes of voting at the shareholder meeting. Enzo's outside counsel also advised American Stock Transfer on November 30 that Rabbani had been terminated as an officer of Enzo. The letter said:

You are hereby instructed not to communicate with, or divulge any information to, any individual who is not an officer, representative or advisor of the Company regarding any matter relating to the Company, including, without limitation, the 2009 Annual Meeting, the record date therefore or any other matter referenced in this letter. Please advise the undersigned immediately if any request for such information is made by Shahram K. Rabbani or any of his representatives or advisors.

The letter asserted that the date for the shareholder meeting had not yet been set by the board.

On December 1, Enzo contracted with a proxy solicitation firm called Altman Group, Inc. for representation "in a proxy contest for board seats at the 2010 Annual Meeting" and discussed the possibility of filing a preliminary proxy. Also on December 1, Enzo sent Rabbani the names, addresses, and security positions of the shareholders of Enzo, as Rabbani had demanded in his Nomination Letter. It insisted again that it was providing the names "as a courtesy" and not because the Nomination Letter was effective or valid.

During this period of time, Rabbani spoke with two of Enzo's largest shareholders to determine whether they would consider supporting a competing slate of director candidates and to express his dissatisfaction with Enzo's management. In December, each of these shareholders advised Weiner that Rabbani had made allegations about Enzo's poor management and performance. At his deposition, Weiner explained that when he met with each of the shareholders, he presented "facts" in response to their inquiries. He acknowledged in his deposition that it was his hope that the "shareholders will make an appropriate and educated decision as to what is in their interest and the best interest of the company."

On December 9, Broadridge sent an email to Rabbani's proxy solicitor, Mackenzie, in response to Mackenzie's inquiry whether there were any "dates on system." The email replied: "r/d 12/29 meet date 2/23/10," presumably referring to the Record Date and Shareholder Meeting date. Mackenzie conveyed this information to Rabbani's attorney in "mid-December." On December 18, the Committee officially set January 29, 2010 as the date for the annual meeting.*fn5

Enzo Files Proxy Statement

On December 23, Enzo filed its definitive proxy statement ("Proxy Statement") indicating that the annual shareholder meeting was being called for January 29, 2010 (1) to elect to the company's board the slate preferred by management; (2) to ratify the appointment of independent auditors for the upcoming fiscal year; and (3) to transact any other business as may properly come before the Shareholder Meeting. The statement included no mention of Rabbani's Nomination Letter or the existence of a competing slate of director candidates. This was the first public notification of the meeting date and the first time that Rabbani and the other Enzo directors who were not on the Committee learned of the date. Rabbani protested on December 28 that the setting of the record date without board action was "defective." On December 31, Enzo provided Rabbani the names, addresses, and security positions of all holders of common stock as of the Record Date of December 29.

Rabbani Files Preliminary Proxy Statement

On January 8, 2010, the date that Rabbani filed this lawsuit in state court, he also filed a preliminary opposition proxy statement ("Rabbani Proxy Statement") and related solicitation materials with the SEC. The Rabbani Proxy Statement reports that Rabbani will be nominating two directors: Andre de Bruin and Steven Katz. It explains that while Rabbani had originally notified Enzo of an intention to nominate three candidates, only two ultimately agreed to be nominated. It also reports that Rabbani "intends to seek to have the meeting for the election of directors postponed to a later date in order to allow adequate time for stockholders to evaluate the director nominees and for us to solicit proxies for the election of the Independent nominees," and that if the meeting were postponed, he intended to nominate a third candidate.

The Rabbani Proxy Statement contained several required disclosures which were not included in the Nomination Letter.*fn6

The defendants contend that this filing was their first notice of an opposing "solicitation" of shareholders by Rabbani, as that term is defined in the securities laws.

Enzo's Supplement to its Proxy Statement

On January 13, Enzo filed a supplement to its Proxy Statement ("the Supplement"). The Supplement acknowledges Rabbani's Proxy Statement and informs shareholders that Rabbani intends to solicit votes for two or three "insurgent director-candidates." While it does not name those candidates or provide any information about them, the Supplement does direct shareholders to the SEC's website, where it says that Rabbani's Proxy Statement could be found. In a section called "Supplemental Information," Enzo discloses as well the Nomination Letter and explains that the Letter "sought to notify the Company of [Rabbani's] purported nomination of a slate of three insurgent Class I directors." It summarizes many of the facts laid out here, including Enzo's position that the Nomination Letter was defective and Rabbani's filing of this litigation.

As of January 18, only one of Rabbani's candidates remained willing to submit his name to the shareholders. Andre de Bruin had withdrawn his name from consideration.*fn7


Rabbani's January 12 amended complaint ("Complaint"), brings three federal claims against all defendants, two state law claims against Enzo, and two state law claims against the individual defendants. The Complaint seeks an injunction postponing the date of the shareholders meeting from January 29 to March 15 and requiring the defendants to acknowledge the "candidates" nominated by Rabbani. It also seeks a declaration that Enzo's objections to the Nomination Letter are without merit, and that Rabbani "followed the process for nominating candidates." Finally, Rabbani seeks recovery of his costs and reasonable attorneys' fees and costs.

The January 11 motion for a preliminary injunction seeks solely to have the Shareholder Meeting postponed from January 29 to March 15. "To obtain a preliminary injunction, a plaintiff must establish: (1) the likelihood of irreparable injury in the absence of such an injunction, and (2) either (a) likelihood of success on the merits or (b) sufficiently serious questions going to the merits to make them a fair ground for litigation plus a balance of hardships tipping decidedly in its favor." Malletier v. Burlington Coat Factory Warehouse Corp., 426 F.3d 532, 537 (2d Cir. 2005) (citation omitted). When the injunction that a party seeks would alter rather than maintain the status quo, the standard is higher. "In such case, the movant must show a clear or substantial likelihood of success." Bronx Household of Faith v. Board of Educ. of City of New York, 331 F.3d 342, 349 (2d Cir. 2003) (citation omitted). Since Rabbani has failed to demonstrate a likelihood of success on the merits, he has necessarily failed to show a substantial likelihood of success. It is therefore unnecessary to explore further whether the relief Rabbani seeks should be characterized as a mandatory injunction.

1. Likelihood of Success

A. Section 14 Claims

The plaintiff asserts three claims under the Securities Exchange Act ("Exchange Act") and the Rules the SEC has promulgated to enforce the Act. Section 14(a) of the Exchange Act prohibits the solicitation of proxies "in contravention of such rules and regulations as the Commission may prescribe as necessary or appropriate in the public interest or for the protection of investors." 15 U.S.C. § 78n(a). The SEC has promulgated Schedule 14A, Rule 14a-101, 17 C.F.R. § 240.14a-101, and Regulation S-K, 17 C.F.R., Part 229 (2006), to implement § 14(a).

The plaintiff alleges that the defendants filed a proxy statement containing material misstatements and omissions of fact, which is prohibited by Rule 14a-9.*fn8 Rule 14a-9 prohibits proxy solicitation "by means of any proxy statement... containing any statement which, at the time and in the light of the circumstances under which it is made, is false or misleading with respect to any material fact, or which omits to state any material fact necessary in order to make the statements therein not false or misleading...." 17 C.F.R. § 240.14a-9. See also Seinfeld v. Gray, 404 F.3d 645, 650 (2d Cir. 2005). The SEC "promulgated Rule 14a-9 with the goal of preserving for all shareholders who are entitled to vote, not just for those who sponsor proposals, the right to make decisions based on information that is not false or misleading." United Paperworkers Int'l Union v. Int'l Paper Co., 985 F.2d 1190, 1198 (2d Cir. 1993). There is an implied right of action under Rule 14a-9. Minzer v. Keegan, 218 F.3d 144, 148 (2d Cir. 2000).

To succeed on a claim of omission, a plaintiff must establish materiality.

Omission of information from a proxy statement is actionable if either the SEC regulations specifically require disclosure of the omitted information in a proxy statement, or the omission makes other statements in the proxy statement materially false or misleading. To succeed on a Rule 14a-9 material omission claim, the plaintiff must show that there was a substantial likelihood that the disclosure of the omitted fact would have been viewed by the reasonable investor as having significantly altered the "total mix" of information made available.

Seinfeld, 404 F.3d at 650 (quoting TSC Indus., Inc. v. Northway, Inc., 426 U.S. 438, 449 (1976)). The "total mix" of information includes only information "reasonably available to the shareholders." Koppel v. 4987 Corp., 167 F.3d 125, 132 (2d Cir. 1999) (citation omitted). Materiality is satisfied if the plaintiff shows "that the proxy solicitation itself, rather than the particular defect in the solicitation materials, was an essential link in the accomplishment of the transaction." Mills v. Electric Auto-Lite Co., 396 U.S. 375, 385 (1970).

Rabbani alleges three violations of federal securities laws in connection with the filing of the Proxy Statement. First, Rabbani asserts that Item 4(a)(1) of Schedule 14A required that the Proxy Statement notify shareholders that Rabbani intended to offer a competing slate of candidates. Second, Rabbani alleges that Rule 14a-6(a) required Enzo to file a preliminary proxy statement. Third, Rabbani alleges that Enzo violated Rule 14a-3(a)(1) by improperly soliciting shareholders prior to the filing of the Proxy Statement. Rabbani has not shown a likelihood of prevailing at trial on any of these three claims.

i. Proxy Statement's Failure to Describe Rabbani's Nomination

Rabbani alleges that the defendants violated Rule 14a-9 by not disclosing in Item 4(a)(1) of Schedule 14A the information from the Nomination Letter. Item 4(a)(1) directs: "If the solicitation is made by the registrant, so state. Give the name of any director of the registrant who has informed the registrant in writing that he intends to oppose any action intended to be taken by the registrant and indicate the action which he intends to oppose." Schedule 14A, Rule 14a-101, 17 C.F.R. § 240.14a-101. The word "action" is left undefined in the regulations.

The parties debate whether the Nomination Letter informed Enzo that Rabbani "intends to oppose" Enzo's slate of directors. As is discussed in further detail near the conclusion of this Opinion, Rabbani never commenced a proxy contest prior to the filing of the Proxy Statement. Enzo contends that its duty to disclose the Nomination Letter in the Proxy Statement was never triggered in the absence of more meaningful evidence that Rabbani actually would act to oppose its nominees.

Assuming solely for purposes of this motion that the plaintiff has shown a likelihood of proving at trial that the Proxy Statement should have included information about the Nomination Letter, Rabbani has nonetheless failed to show a likelihood of proving that the Supplement was inadequate to cure this alleged violation of Rule 14a-9. The Supplement identified Rabbani as a director who intended to oppose the slate of directors nominated by Enzo's management and provided information to shareholders about where Rabbani's Proxy Statement could be found. The Supplement was issued sixteen days (or eleven business days) before the Shareholder Meeting. As such it was sufficiently timely to allow shareholders to receive and consider the information. See Caruso v. Metex Corp., No. CV 89-0571, 1992 WL 237299, at *10-11 (E.D.N.Y. July 30, 1992) (collecting cases).

Rabbani's hearing submissions do not show how the Supplement failed to cure the omission.*fn9 Indeed, he barely mentions the Supplement, even though its filing and its impact on this motion were a principal focus of the parties' January 12 conference with the Court. In sum, Rabbani has not shown a likelihood of success on his claim that the Proxy Statement was filed in violation of Rule 14a-9.

ii. Enzo's Duty to File a Preliminary Proxy Statement

Rabbani alleges that the defendants violated SEC Rule 14a-6(a) by failing to file a preliminary proxy statement. Rule 14a-6(a) requires the filing of a preliminary proxy statement with the SEC ten calendar days in advance of the filing of the final document, but provides exceptions to this requirement. It reads in pertinent part as follows:

Five preliminary copies of the proxy statement and form of proxy shall be filed with the Commission at least 10 calendar days prior to the date definitive copies of such material are first sent or given to security holders.... A registrant, however, shall not file with the Commission a preliminary proxy statement, form of proxy or other soliciting material to be furnished to security holders concurrently therewith if the solicitation relates to an annual (or special meeting in lieu of the annual) meeting,... if the solicitation relates to any meeting of security holders at which the only matters to be acted upon are:

(1) The election of directors; [and/or]

(2) The election, approval or ratification of accountant(s);....

17 C.F.R. § 240.14a-6(a) (emphasis supplied). Thus, when the business of the meeting will be limited to the items described in the rule, which includes the election of directors, no preliminary document must be filed. But, this exception does not apply when the action to be taken at the meeting is contested. The Rule explains that: "This exclusion from filing preliminary proxy material does not apply if the registrant comments upon or refers to a solicitation in opposition in connection with the meeting in its proxy material." Id. (emphasis supplied).

The term "solicitation" is defined as:

(i) Any request for a proxy whether or not accompanied by or included in a form of proxy;

(ii) Any request to execute or not to execute, or to revoke, a proxy; or

(iii) The furnishing of a form of proxy or other communication to security holders under circumstances reasonably calculated to result in the procurement, withholding or revocation of a proxy.


17 C.F.R. § 240.14a-1(l). Note 3 to Rule 14a-6 provides: "For purposes of the exclusion from filing preliminary proxy material, a 'solicitation in opposition' includes: (a) Any solicitation opposing a proposal supported by the registrant...." 17 C.F.R. § 240.14a-6.

Rabbani has not shown a likelihood of proving at trial that Enzo violated the federal securities laws by failing to file a preliminary proxy statement. Rabbani's contention is that the Proxy Statement should have been preceded by a preliminary proxy statement since the Nomination Letter was a solicitation that triggered the exclusion under Rule 14a-6(a). Because the Nomination Letter did not constitute a "solicitation," however, there was no duty under Rule 14a-6(a) to file a preliminary proxy statement. The Nomination Letter was directed at Enzo, not at its shareholders. It was not a request for a proxy, to execute or revoke a proxy, or to furnish a form of proxy. Therefore, Rabbani has not shown that he is likely to succeed on the claim premised on Rule 14a-6(a).

Rabbani points to SEC guidance to support his argument that Enzo was required to file a preliminary proxy statement. SEC guidance is entitled to at least "some deference." Reno v. Koray, 515 U.S. 50, 61 (1995); see also Conroy v. New York State Dept. of Correctional Services, 333 F.3d 88, 95 (2d Cir. 2003). The SEC guidance upon which plaintiff relies, however, does not assist him. The SEC published the following question and answer in 2001:

Q: May a registrant rely on Rule 14a-6(a) to file a proxy statement in definitive form in a contested proxy solicitation for the election of directors by simply not referring to the solicitation in opposition in its proxy statement when the registrant knows, or reasonably should know, of the solicitation in opposition?

A: No. Rule 14a-9 prohibits a registrant from omitting a material fact from its proxy statement at the time of the solicitation. The staff believes that it is inconsistent with this provision of Rule 14a-9 when the initial definitive proxy statement does not disclose the existence of a solicitation in opposition when the registrant knows, or reasonably should know, of a solicitation in opposition. The staff believes the existence of alternative nominees is material to security holders' voting decisions. Further, it is not appropriate for the registrant to omit this information from its initial proxy statement and wait to address the solicitation in opposition at a later time in the solicitation. It is also inappropriate to merely disclose the existence of the solicitation in opposition in a press release issued at the same time the registrant mails to shareholders the definitive proxy statement that omits the information.

SEC Division of Corporation Finance Manual of Publicly Available Telephone Interpretations, Third Supplement, July 2001, Question

I.G.2, available at phonesupplement3.htm (last visited January 26, 2010) (emphasis supplied).

This guidance from the SEC is uncontroversial: when there has been a solicitation in opposition to the company's proposal, a company cannot avoid its obligation to file a preliminary proxy statement by simply omitting any reference to the solicitation in its proxy statement. That said, the guidance still requires that there be a "solicitation in opposition" to invoke the exception to Rule 14a-6(a).

iii. Enzo's Oral Solicitation of its Shareholders

Rabbani's final federal claim is that the defendants improperly solicited shareholders before the company filed its Proxy Statement on December 23, in violation of Rule 14a-3(a)(1). Specifically, Rabbani asserts that Weiner met with two of Enzo's largest shareholders in early and mid-December to discuss Rabbani's communications with them about waging a proxy fight and did not provide either shareholder at that time with Enzo's proxy materials.

Rule 14a-3 prohibits solicitation "unless each person solicited is concurrently furnished or has previously been furnished with: (1) A publicly-filed preliminary or definitive proxy statement, in the form and manner described in § 240.14a-16, containing the information specified in Schedule 14A (§ 240.14a-101)." 17 C.F.R. § 240.14a-3(a). See MONY Group, Inc. v. Highfields Capital Management, L.P., 368 F.3d 138, 147 (2d Cir. 2004)(finding irreparable harm from violation of Rule 14a-3).

The SEC has interpreted Rule 14a-3 broadly to encompass any activity which in the totality of the circumstances in reasonably calculated to influence votes. Its interpretation is entitled to deference. See S.E.C. v. Cavanagh, 445 F.3d 105, 114 n.20 (2d Cir. 2006) ("We owe deference to the SEC's release"); Gryl ex rel. Shire Pharmaceuticals Group PLC v. Shire Pharmaceuticals Group PLC, 298 F.3d 136, 145 n.8 (2d Cir. 2002) ("[B]ecause the SEC's 1996 Release is connected to the agency's rule-making function... [it] must be accorded weight by us."). In 2004, the SEC advised that

[T]he proxy rules apply to any person seeking to influence the voting of proxies, regardless of whether the person is seeking authorization to act as a proxy. The rules apply not only to direct requests to furnish, revoke or withhold proxies, but also to communications that may indirectly accomplish such a result or constitute a step in a chain of communications designed ultimately to accomplish such a result. SEC v. Okin, 132 F.2d 784, 786 (2d Cir. 1943). The issue is whether the challenged communication, seen in the totality of circumstances, is "reasonably calculated" to influence the shareholders' votes. Trans. World Corp. v. Odyssey Partners, 561 F. Supp. 1311, 1320 (S.D.N.Y. 1983).

In the matter of John Joslyn, et al., Exchange Act Release No. 50588, 83 S.E.C. Docket 3127, 2004 WL 2387455, at *11 (October 26, 2004).

Weiner testified that he met with two shareholders at their request to "present the facts." Rabbani had been highly critical of Enzo's management in his conversations with these shareholders and they contacted Weiner to hear management's response to his charges and to discuss other matters concerning the company. While Weiner acknowledged in his deposition that he believed at the time of that meeting that it was in the shareholders' best interest to vote for the candidates nominated by Enzo's management, he was not asked and did not state in that deposition that he asked the shareholders either to vote for the management slate of candidates or to withhold their vote for any competing slate of director candidates, or that he encouraged them to do so in words or substance. Rabbani has not pointed to any passage from the Weiner deposition or any other evidence that suggests that Weiner's responses to the shareholders' inquiries was, in the totality of the circumstances, reasonably calculated to influence their votes on the upcoming election of directors. Indeed, as of that time, Rabbani had failed to take the several steps that were available to him to inaugurate a proxy battle and with each passing day the likelihood of a battle waned. With a more developed record, Rabbani may be able to succeed at trial in showing a violation of Rule 14a-3, but as the record now stands he has not shown an improper solicitation or that he is likely to succeed on the merits of this claim.

B. State Law Claims

Rabbani brings four state law claims. He asserts that the individual defendants breached their fiduciary duties to him and violated § 717(a) of the New York Business Corporation Law ("BCL"). He alleges that Enzo breached its Bylaws and their implied covenant of good faith and fair dealing. Since it is the company that will hold the Shareholder Meeting, only Rabbani's claims against the company will be addressed.

i. Breach of Contract

Rabbani alleges that Enzo is liable for breach of contract by refusing to acknowledge the Nomination Letter, in violation of Article II, § 15 of Enzo's Bylaws.*fn10 Under New York law, the elements of a breach of contract claim are formation of a contract between the parties, performance by the plaintiff, breach of the contract by the defendant, and damages.*fn11 Eternity Global Master Fund Ltd. v. Morgan Guar. Trust Co. of N.Y., 375 F.3d 168, 177 (2d Cir. 2004). The bylaws of a corporation act as a contract between shareholders and the corporation. Management Technologies, Inc. v. Morris, 961 F.Supp. 640, 646 (S.D.N.Y. 1997).

Rabbani has not shown a likelihood of proving at trial that Enzo breached a contract with him by violating its Bylaws.*fn12 The Bylaws expressly permit Enzo to "refuse to acknowledge the nomination of any person not made in compliance with" the Bylaws. As described above, Rabbani has not shown a likelihood of proving at trial that the Nomination Letter complied that requirement.

ii. Good Faith and Fair Dealing

Rabbani alleges that Enzo violated the implied duty of good faith and fair dealing by "(i) refusing to acknowledge Rabbani's slate of directors, (ii) initially refusing to identify any specific deficiencies in the Nomination Letter, (iii) subsequently identifying only false, baseless, inadequate and/or pretextual 'reasons' for refusing to acknowledge Rabbani's slate of directors, and (iv) accelerating the date of the shareholders' meeting." "Under New York law, a duty of good faith and fair dealing is implied in every contract. The duty comprises any promises which a reasonable person in the position of the promisee would be justified in understanding were included in the contract." National Market Share, Inc. v. Sterling Nat. Bank, 392 F.3d 520, 525 (2d Cir. 2004) (citation omitted). New York law, however, "does not recognize a separate cause of action for breach of the implied covenant of good faith and fair dealing when a breach of contract claim, based upon the same facts, is also pled." Harris v. Provident Life and Acc. Ins. Co., 310 F.3d 73, 81 (2d Cir. 2002).

As already explained, Rabbani has not shown that any claim that hinges on the rejection of the Nomination Letter has merit. Similarly, Rabbani has not shown a likelihood of proving at trial that Enzo breached the implied covenant of good faith and fair dealing by scheduling the shareholder meeting for January 29.

Enzo's annual shareholder meetings were required by its Bylaws to be held in January and that had been the company's consistent practice. Enzo's October SEC filing predicted a January meeting date, and Rabbani relied on that understanding in choosing the date for the submission of his Nomination Letter; he submitted the Letter roughly sixty days before the anticipated meeting date, as required by the Bylaws. While February 9 was in contention as a date for the Shareholder Meeting for two days (between November 23 and November 25), there was never any board action with respect to that date. Indeed, there was never any official action with respect to any date except January 29, which was approved by the Committee on December 18.

As a corollary to this analysis, no "reasonable person" in Rabbani's position would have been justified in relying on the proposed date of February 9. National Market Share, Inc., 392 F.3d at 525. Nor is there reasonable support for any expectation that the meeting would be pushed to any date past January. In the past twenty years, Enzo had not held an annual meeting other than in January and none of the other dates Enzo suggested to its board for the meeting (January 26 and January 19) was in February. While Rabbani's counsel apparently learned in "mid-December" that Enzo was preparing for a meeting date of February 23, by December 23 Enzo gave official notice that the meeting would be held on January 29. Thus, Rabbani only had some basis for approximately one week to believe that the meeting would be held on February 23. In sum, Rabbani has not shown a likelihood of prevailing on this second common law claim.

2. Irreparable Harm

Even if Rabbani were able to show a likelihood of success on the merits, he would be required to establish as well that he will suffer irreparable harm if the annual meeting date is not adjourned. "It is well-established that a transaction --particularly a change-of-control transaction -- that is influenced by noncompliance with the disclosure provisions of the various federal securities laws can constitute irreparable harm." MONY Group, Inc., 368 F.3d at 147.

Rabbani has not succeeded in showing that he will suffer irreparable harm principally because he has not shown a sufficiently serious effort to run a competing slate of candidates for the Enzo board of directors. He is not entitled to have the annual meeting adjourned so that he can have a second chance to mount a meaningful proxy fight. By January 18, Rabbani's slate of candidates had dwindled from three to one and Rabbani's late-filed Proxy Statement was apparently never approved by the SEC. Simply stated, Rabbani has failed to demonstrate sufficient diligence to warrant the extraordinary relief that he seeks.

The parties disagree as to what measures Rabbani could have taken to launch a public proxy fight. Rabbani asserts that he could not have filed a preliminary proxy without knowing the date of the shareholder meeting.*fn13 Enzo asserts that Rabbani had several options under Rule 14a-12 to demonstrate his seriousness and publicize his bid and that he availed himself of none of them.

It appears that Rabbani did indeed have several options open to him to demonstrate an intent to wage a proxy battle. First, he could have submitted a Nomination Letter to Enzo that complied with Enzo's Bylaws and promptly filed a preliminary proxy statement with the SEC that complied with the SEC disclosure rules. By submitting a defective Nomination Letter and delaying his submission of the Rabbani Proxy Statement to the SEC until virtually the eve of the annual meeting, he guaranteed that he would be unable to engage in a proxy battle for the January 29 meeting. Nor can he properly excuse his delay in filing the Rabbani Proxy Statement by indicating that he wanted to have Enzo's bill of particulars of the deficiencies in his Nomination Letter. Enzo had no duty to provide him advice and counsel on how to wage a proxy battle with the company. Similarly, he cannot excuse his delay in filing by pointing to the fact that he did not learn that the company had settled on January 29 as the meeting date until December 23. As described above, Rabbani was on sufficient notice of the likelihood that the meeting would be scheduled for January to prepare his submission on a timely basis. As it was, he did not file the Rabbani Proxy Statement with the SEC until January 8, two weeks after learning of the date for the meeting.

With a filing of a preliminary proxy statement, Rabbani could even have begun solicitation without incurring the expense of immediately sending proxy materials to shareholders. Rule 14a-2 describes solicitations made through a newspaper advertisement as solicitations to which Rule 14a-3 does not apply. It states that Rule 14a-3 does not apply to

Any solicitation through the medium of a newspaper advertisement which informs security holders of a course from which they may obtain copies of a proxy statement, form of proxy and any other soliciting material and does no more than:

(i) Name the registrant;

(ii) State the reason for the advertisement; and

(iii) Identify the proposal or proposals to be acted upon by security holders.

17 C.F.R. § 240.14a-2(a)(6)(emphasis added). Similarly, Rule 14a-3(f) provides:

The provisions of paragraph (a) of this section shall not apply to a communication made by means of speeches in public forums, press releases, published or broadcast opinions, statements, or advertisements appearing in a broadcast media, newspaper, magazine or other bona fide publication disseminated on a regular basis, provided that:

(1) No form of proxy, consent or authorization or means to execute the same is provided to a security holder in connection with the communication; and

(2) At the time the communication is made, a definitive proxy statement is on file with the Commission pursuant to § 240.14a-6(b).

17 C.F.R. § 14a-3(f).

Moreover, Rabbani could even have begun his proxy battle in advance of filing a proxy statement with the SEC. While Rule 14a-3(a)(1) prohibits solicitation unless each person solicited has been furnished with either a preliminary or a definitive proxy "containing the information specified in Schedule 14A," 17 C.F.R. § 14a-3(a)(1), there are exceptions to that rule.

Rule 14a-12 is called "Solicitation before furnishing a proxy statement" and is part of the "new regime" that started in 1999 to "liberaliz[e] communications that can be made... without being accompanied with or preceded by delivery of a proxy statement." 1 Sec. Law Handbook § 17-8 (2009). "Rule 14a-12 permits a person to commence what would otherwise be deemed a solicitation prior to delivery of a proxy statement provided the conditions of the rule are complied with." Id. The rule says:

(a) Notwithstanding the provisions of § 240.14a-3(a), a solicitation may be made before furnishing security holders with a proxy statement meeting the requirements of § 240.14a-3(a) if:

(1) Each written communication includes: [the identity of the participants and their interests, a "prominent legend" "advising security holders to read the proxy statement when it is available"]

(2) A definitive proxy statement meeting the requirements of § 240.14a-3(a) is sent or given to security holders solicited in reliance on this section before or at the same time as the forms of proxy... are furnished to or requested from security holders.

17 C.F.R. § 240.14a-12(a) (emphasis supplied). Part (b) requires the solicitor to file with the SEC the information that it publishes, sends, or gives to security holders and to include "a cover page in the form set forth in Schedule 14A." Id. at 14a-12(b). Thus, under this new regime, insurgents... can commence their solicitation without having filed the proxy statement, provided no form of proxy is furnished to security holders; the identity and interests of the participants are disclosed...; and a written proxy statement meeting the requirements of Regulation 14A is furnished to security holders solicited pursuant to Rule 14a-12 at the earliest practicable date.... 1 Sec. Law Handbook § 17:8. Finally, Rule 14a-3's prohibitions on solicitation without delivery of a proxy statement do not apply to "Any solicitation made otherwise than on behalf of the registrant where the total number of persons solicited is not more than ten." Id. § 240.14a-2(b)(2). Rabbani did not pursue any of these options to initiate his proxy battle.

In sum, Rabbani had several options in conducting a timely proxy battle that would have given him the ability to contest the Enzo slate of candidates without jeopardizing the annual meeting date. He took none of them. And, within a few weeks time, his slate of candidates imploded. Whether this failure to show a serious commitment to the proxy battle is analyzed as a failure to demonstrate irreparable harm or a delay that deprives him of the right to seek injunctive relief, see Merrill Lynch Inv. Managers v. Optibase, Ltd., 337 F.3d 125, 132 (2d Cir. 2003), it is fatal to his motion for a preliminary injunction. Simply put, a threat to engage in a proxy contest is not a proxy contest.

Rabbani counters that he simply did not understand until the Proxy Statement was filed that there was "any urgency." This argument is unpersuasive. Rabbani's decision to serve the Nomination Letter on November 20 is compelling evidence that he well understood that the risk that the annual meeting would be held, as it always had been, in January, and that if he wanted to run a proxy contest time was of the essence. While he has shown that Enzo waited until the last possible moment to reveal to him the actual date of the meeting, that tactical decision does not excuse his delay in acting to protect his interests. Rabbani may have hoped that Enzo would not hold an annual meeting and would defer a vote of directors to a special meeting held after January, but he had no reliable indication that that would occur and plenty of evidence to the contrary. Rabbani took a gamble and lost.

For the reasons recited above, Rabbani has also failed to carry his burden of showing that the balance of equities favors him. Enzo's expense in preparing for its annual meeting would be lost, and it would have to prepare for a special meeting to conduct its business if this motion were granted. Because Rabbani has not shown that he acted with sufficient diligence to wage a proxy battle, he has not shown that he is entitled to impose this financial and administrative burden on Enzo.


Plaintiff's January 11, 2010 motion for a preliminary injunction is denied.


Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.